McCarthy Asset Management’s Idexx Laboratories IDXX Stock Holding History

McCarthy Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-150	Closed	-$82K	–	143
2022 Q1	$82K	Hold	150	–	–	0.06%	64
2021 Q4	$99K	Sell	150 -20	-12%	-$12.6K	0.07%	59
2021 Q3	$106K	Hold	170	–	–	0.08%	54
2021 Q2	$107K	Hold	170	–	–	0.08%	59
2021 Q1	$83K	Hold	170	–	–	0.06%	66
2020 Q4	$85K	Buy	+170	New	+$76.1K	0.07%	62

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

McCarthy Asset Management's IDXX Position: Q2 2022 in Review

McCarthy Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 150 shares — an estimated $82K sold.

McCarthy Asset Management first reported a position in IDXX in Q4 2020 and held it in 6 quarters. The position peaked at $107K in Q2 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

McCarthy Asset Management reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
McCarthy Asset Management sold 150 Idexx Laboratories shares in Q2 2022, an estimated $82K.
McCarthy Asset Management first reported a position in Idexx Laboratories in Q4 2020 and held it in 6 quarters.
McCarthy Asset Management's Idexx Laboratories position peaked at $107K in Q2 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.